News About: Pharm. Industry
Rebate ban glooms pharmaceutical industry
Prospects have been grim for Korean firms, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs. Generic drugs have long been the competitive edge...
Pharmaceutical shares hit by anti-rebate law
Influenced by the recent passage of an anti-rebate bill and poor performance of local leading drugmakers in the first quarter, pharmaceutical shares posted losses on April 29.
"This shows the current pharmaceutical...
Ilyang to go global
Ilyang Pharm is reported to enter into a distribution agreement with a leading multinational drug manufacturer to expand the sales of its new anticerant “ilaprazole” on a global basis.
Under the proposed contract, ...
Pyronaridine-artesunate combination drug by Shin Poong is as effective as Coartem, study claims
Pyronaridine-artesunate combination pill Pyramax is as effective against falciparum malaria as the current gold standard anti-malarial combo artemether-lumefantrine which is marketed by Novartis under the brandname Co...
Boehringer Ingelheim Korea’s work-life balance system satisfies 90% of employees
“Study hard, work hard" has long been Koreans' catch phrase to make their small, resource-poor country the world's 14th-largest economy.
The only problem with this time-old growth paradigm is it can neither last fo...
National Assembly passes bill over anti-rebate
The National Assembly on April 28 approved a bill to bring criminal charges against doctors and pharmacists who take rebates from drug makers when purchasing medicine.
After the six-month grace period, the regulati...
Drug makers, doctors at odds over bill against rebates
A dispute is brewing between pharmaceutical companies and doctors, after the National Assembly passed a bill to stop the practice of giving “illegal rebates'' here.
Last August the Ministry of Health and Welfare l...
Zuellig, Kyundongsa to set up JV
Zuellig Pharma Korea and Kyundongsa plan to establish a joint venture through their joint equity investment.
ZPK will provide distribution and logistics expertise to the joint venture on a contract basis, saying th...
Yuyu enjoys robust sales of Yuclid
Yuyu Pharm has recently had its big smiles over the better-than-expected revenues of Yuclid tablets, of a combination of ticlopidine and ginkgo biloba extract.
The company said Yuclid achieved 2.6 billion won in sa...
Hanall wins local patent for combination drug
Hanall Biopharma (formerly Hanall Pharmaceutical) announced on April 26 that it has acquired a patent for 'HL-012', a combination drug containing simvastatin and aspirin.
The patent is characterized by its innovate...
